MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 139 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $325,557 | +950.2% | 1,089 | +317.2% | 0.00% | – |
| Q1 2021 | $31,000 | -80.3% | 261 | -80.7% | 0.00% | – |
| Q4 2020 | $157,000 | +220.4% | 1,355 | +233.7% | 0.00% | – |
| Q3 2020 | $49,000 | -53.3% | 406 | -58.5% | 0.00% | – |
| Q2 2020 | $105,000 | +517.6% | 978 | +249.3% | 0.00% | – |
| Q1 2020 | $17,000 | -85.2% | 280 | -77.8% | 0.00% | – |
| Q4 2019 | $115,000 | -68.5% | 1,261 | -70.2% | 0.00% | – |
| Q3 2019 | $365,000 | -85.1% | 4,235 | -81.8% | 0.00% | -100.0% |
| Q2 2019 | $2,445,000 | -25.9% | 23,329 | -11.5% | 0.00% | -33.3% |
| Q1 2019 | $3,301,000 | +1526.1% | 26,350 | +1366.3% | 0.00% | – |
| Q4 2018 | $203,000 | -67.3% | 1,797 | -38.0% | 0.00% | – |
| Q3 2018 | $620,000 | -21.9% | 2,898 | +2.0% | 0.00% | -100.0% |
| Q2 2018 | $794,000 | +467.1% | 2,841 | +136.8% | 0.00% | – |
| Q1 2018 | $140,000 | – | 1,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 463,000 | $99,142,000 | 4.55% |
| Rock Springs Capital Management LP | 342,000 | $73,232,000 | 2.65% |
| ACUTA CAPITAL PARTNERS, LLC | 33,000 | $7,066,000 | 2.52% |
| HealthCor Management, L.P. | 262,860 | $56,286,000 | 1.87% |
| Baker Brothers Advisors | 1,169,278 | $250,377,000 | 1.65% |
| EMORY UNIVERSITY | 11,391 | $2,439,000 | 1.60% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 8,690 | $1,862,000 | 1.48% |
| GREAT POINT PARTNERS LLC | 40,400 | $8,651,000 | 1.35% |
| SHIKIAR ASSET MANAGEMENT INC | 15,341 | $3,285,000 | 1.28% |
| ARMISTICE CAPITAL, LLC | 80,000 | $17,130,000 | 1.03% |